Cost-effectiveness of Pembrolizumab as Second-line Therapy for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma in Sweden

T Srivastava; VS Prabhu; HJ Li; RF Xu; N Zarabi; YC Zhong; JM Pellissier; RF Perini; Ronald de Wit; R Mamtani

doi:10.1016/j.euo.2018.09.012

Cost-effectiveness of Pembrolizumab as Second-line Therapy for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma in Sweden

T Srivastava
, VS Prabhu
, HJ Li
, RF Xu
, N Zarabi
, YC Zhong
, JM Pellissier
, RF Perini
, Ronald de Wit
, R Mamtani

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

13 Citations (Scopus)

39 Downloads (Pure)

Original language	English
Pages (from-to)	663-670
Number of pages	8
Journal	European urology oncology
Volume	3
Issue number	5
DOIs	https://doi.org/10.1016/j.euo.2018.09.012
Publication status	Published - 2020

Research programs

EMC OR-01

Access to Document

10.1016/j.euo.2018.09.012

Repub_131651_O-A.pdfFinal published version, 951 KB

http://hdl.handle.net/1765/131651

Cite this

@article{70792b4923c34a798cf3718153bf201e,

title = "Cost-effectiveness of Pembrolizumab as Second-line Therapy for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma in Sweden",

author = "T Srivastava and VS Prabhu and HJ Li and RF Xu and N Zarabi and YC Zhong and JM Pellissier and RF Perini and \{de Wit\}, Ronald and R Mamtani",

year = "2020",

doi = "10.1016/j.euo.2018.09.012",

language = "English",

volume = "3",

pages = "663--670",

journal = "European urology oncology",

issn = "2588-9311",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - Cost-effectiveness of Pembrolizumab as Second-line Therapy for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma in Sweden

AU - Srivastava, T

AU - Prabhu, VS

AU - Li, HJ

AU - Xu, RF

AU - Zarabi, N

AU - Zhong, YC

AU - Pellissier, JM

AU - Perini, RF

AU - de Wit, Ronald

AU - Mamtani, R

PY - 2020

Y1 - 2020

U2 - 10.1016/j.euo.2018.09.012

DO - 10.1016/j.euo.2018.09.012

M3 - Article

C2 - 31412001

SN - 2588-9311

VL - 3

SP - 663

EP - 670

JO - European urology oncology

JF - European urology oncology

IS - 5

ER -